Skip to main content
High RiskFDAfda-F-1049-2020UNDECLARED ALLERGEN

Dietary supplements, 60 capsules, UPC 15033-61832, Product # 832060, labeled under the following brands and product names, packaged in ...

Category
Units Affected
95
Recall Date
July 16, 2020
Issuing Agency
Hazard
Undeclared Allergen

FDA Recall Notice

Source: U.S. Food and Drug Administration (FDA) — official FDA notice for recall FDA-F-1049-2020.

Various branded dietary supplements may contain undeclared soy.

Corrective Action (per FDA)

Source: U.S. Food and Drug Administration (FDA) — official FDA notice for recall FDA-F-1049-2020.

Recall terminated by FDA.

✅ What you should do

  1. Stop using the product if you own it.
  2. Check the model number, lot code, or sell-by date against the recall notice above.
  3. Contact Provident Nutraceutical Div. Of Ortho Molecular Products Inc or the retailer where you bought it for a refund, replacement, or repair.
  4. For the most current official instructions, visit the FDA recall page.
  5. If you've been hurt by this product, report the incident to FDA.

Consumer Contact (per FDA)

Source: U.S. Food and Drug Administration (FDA) — official FDA notice for recall FDA-F-1049-2020.

Provident Nutraceutical div. of Ortho Molecular Products Inc

FDA

About the U.S. Food and Drug Administration

The FDA regulates drugs, medical devices, food, cosmetics, and tobacco. Adverse event reports and recall notices are the main public safety signal.

Visit FDA.gov →

📣 Report a food, supplement, or cosmetic problem to the FDA

If you had a reaction, found contamination, or experienced a labeling problem with this product, report it to the FDA. The agency uses consumer reports to track emerging safety signals and trigger recalls.

How to report to FDAFile a report at FDA

Provident Nutraceutical Div. Of Ortho Molecular Products Inc Recall FAQ

Provident Nutraceutical Div. Of Ortho Molecular Products Inc is the subject of a supplements safety report: Dietary supplements, 60 capsules, UPC 15033-61832, Product # 832060, labeled under the following brands and product names, packaged in .... The notice was published on July 16, 2020 by the U.S. Food and Drug Administration (FDA). Approximately 95 units are potentially affected.